Premier Biomedical (BIEI) Financials

$2.9 M

Mkt cap, 31-Oct-2017

$10.4 K

Revenue Q1, 2018
Gross profit (Q1, 2018)4.3 K
Gross profit margin (Q1, 2018), %41.7%
Net income (Q1, 2018)566.3 K
Cash, 31-Mar-201879.2 K

Revenue/Financials

Income Statement

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Revenue

39.8 k

Cost of goods sold

25.4 k

Gross profit

14.3 k

Gross profit Margin, %

36%

R&D expense

217.4 k196.2 k234.1 k113.9 k184.3 k

General and administrative expense

3 m223.4 k133.3 k191.4 k196.7 k

Operating expense total

3.2 m419.6 k367.4 k305.2 k1.3 m

Interest expense

400.4 k41.6 k198.9 k817.4 k351.5 k

Net Income

(4.9 m)(1.4 m)(2.6 m)(1.8 m)(3.8 m)

Quarterly

USDQ1, 2014Q2, 2014Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q3, 2017Q1, 2018

Revenue

24.3 k10.4 k

Cost of goods sold

11.1 k6.1 k

Gross profit

13.2 k4.3 k

Gross profit Margin, %

54%42%

R&D expense

2.7 k52.2 k56.9 k59.7 k10.1 k49.5 k46.1 k184.3 k

General and administrative expense

47.8 k40.3 k25.5 k44.8 k49.5 k42 k36.6 k37 k34.5 k

Operating expense total

50.6 k92.5 k82.4 k104.5 k59.6 k91.5 k82.6 k243.6 k74.1 k

Interest expense

29.5 k49.6 k48.5 k217.1 k202.4 k284 k37.1 k64.1 k

Net Income

(307.3 k)(209.8 k)(936.6 k)(188.8 k)(415.1 k)(722.1 k)(435.1 k)3.7 m566.3 k

Balance Sheet

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Cash

15.8 k102.6 k35.4 k22.4 k83.7 k

Accounts Receivable

171.5 m312

Inventories

84.8 k

Current Assets

21.8 k115.5 k66.5 k33.9 k203.6 k

PP&E

3.7 k5.1 k3.6 k5.1 k5.5 k

Total Assets

25.5 k120.6 k70.2 k39 k209.1 k

Accounts Payable

122.3 k147.5 k188.3 k220.7 k346.8 k

Current Liabilities

274.5 k188.4 k346.5 k699.7 k2.8 m

Total Liabilities

699.7 k2.8 m

Additional Paid-in Capital

6.5 m8.1 m10.5 m11.9 m13.4 m

Retained Earnings

(8.2 m)(10.8 m)(12.6 m)(16.3 m)

Total Equity

(249 k)(67.8 k)(276.3 k)(660.7 k)(2.6 m)

Financial Leverage

-0.1 x-1.8 x-0.3 x-0.1 x-0.1 x

Quarterly

USDQ1, 2014Q2, 2014Q3, 2017Q1, 2018

Cash

113.6 k199.4 k102.5 k79.2 k

Accounts Receivable

834

Inventories

108 k79.4 k

Current Assets

119.1 k231.7 k218.8 k192 k

PP&E

3.5 k3.2 k5.9 k6.9 k

Total Assets

122.6 k234.9 k224.7 k198.9 k

Accounts Payable

17.8 k42.8 k350.1 k346.9 k

Current Liabilities

20.8 k60 k2.9 m2.1 m

Total Liabilities

2.9 m2.1 m

Additional Paid-in Capital

7.1 m7.5 m12.8 m13.8 m

Retained Earnings

(15.4 m)(15.8 m)

Total Equity

101.8 k174.9 k(2.7 m)(1.9 m)

Financial Leverage

1.2 x1.3 x-0.1 x-0.1 x

Cash Flow

Annual

USDFY, 2013FY, 2014FY, 2015FY, 2016FY, 2017

Net Income

(4.9 m)(1.4 m)(2.6 m)(1.8 m)(3.8 m)

Depreciation and Amortization

767 954 1.5 k2.1 k2.3 k

Accounts Receivable

(312 )

Inventories

(84.8 k)

Accounts Payable

33.7 k25.2 k40.8 k32.5 k126.1 k

Cash From Operating Activities

(428.2 k)(639.1 k)(462.2 k)(483.6 k)(509.4 k)

Purchases of PP&E

(1.4 k)(2.4 k)(3.5 k)(2.7 k)

Cash From Investing Activities

(1.4 k)(2.4 k)(3.5 k)(2.7 k)

Cash From Financing Activities

405.1 k728.3 k395 k474.2 k573.4 k

Interest Paid

20.8 k32.6 k13.5 k5.6 k

Quarterly

USDQ1, 2014Q2, 2014Q3, 2014Q1, 2015Q2, 2015Q3, 2015Q1, 2016Q2, 2016Q3, 2016Q1, 2018

Net Income

(307.3 k)(209.8 k)(936.6 k)(188.8 k)(415.1 k)(722.1 k)(435.1 k)566.3 k

Depreciation and Amortization

233 466 591

Accounts Receivable

312

Inventories

5.4 k

Accounts Payable

(104.6 k)(79.6 k)34.6 k209.5 k237.9 k299.4 k83.4 k143.7 k210.1 k42

Cash From Operating Activities

(304.5 k)(418.6 k)(62.5 k)

Purchases of PP&E

(2 k)

Cash From Investing Activities

(2 k)

Cash From Financing Activities

402.3 k602.3 k60 k

Interest Paid

32.6 k32.6 k

Ratios

USDY, 2018

Financial Leverage

-0.1 x
Report incorrect company information